HLB Therapeutics Co Ltd (115450)

Currency in KRW
1,166
-124(-9.61%)
Closed·
Trading near 52-week Low
115450 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1,1591,289
52 wk Range
1,1594,160
Key Statistics
Bid/Ask
1,158.00 / 1,163.00
Prev. Close
1,166
Open
1,251
Day's Range
1,159-1,289
52 wk Range
1,159-4,160
Volume
1.22M
Average Volume (3m)
785.95K
1-Year Change
-60.9474%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
115450 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low Price / Book multiple

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Earnings

Latest Release
Aug 13, 2026
EPS / Forecast
-101,00 / --
Revenue / Forecast
12,56B / --
EPS Revisions
Last 90 days

115450 Income Statement

Compare 115450 to Peers and Sector

Metrics to compare
115450
Peers
Sector
Relationship
P/E Ratio
−5.7x−9.4x−0.2x
PEG Ratio
0.02−0.020.00
Price/Book
0.7x1.7x2.6x
Price / LTM Sales
1.6x5.6x2.7x
Upside (Analyst Target)
-87.8%72.2%
Fair Value Upside
Unlock15.2%12.4%Unlock

HLB Therapeutics Co.,Ltd., a biotech company, develops pharmaceutical products in South Korea and internationally. It is developing GBT-201 using Thymosin beta for the treatment of ophthalmic diseases, such as dry eye syndrome and neurotrophic keratopathy; and OKN-007 for the treatment of glioblastoma brain tumor. It is also involved in the wholesale of vaccines, as well as manufactures electrical and electronic components, such as motors, pumps, and transformers. The company was formerly known as G-treeBNT Co., Ltd. and changed its name to HLB Therapeutics Co.,Ltd. in December 2021. HLB Therapeutics Co.,Ltd. was founded in 2000 and is headquartered in Seongnam-si, South Korea.

Employees
49

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
3,26M3,70%4,22B
Other Institutional Investors
17,30M19,63%22,42B
Public Companies & Retail Investors
67,58M76,67%87,58B
Total
88,14M100,00%114,23B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
HLB Co., Ltd.14,90%13 134 83417 022 745
Vanguard Capital Management, LLC3,32%2 927 7093 794 311

FAQ

What Is the HLB Therapeutics (115450) Stock Price Today?

The HLB Therapeutics stock price today is 1 166 KRW.

What Stock Exchange Does HLB Therapeutics Trade On?

HLB Therapeutics is listed and trades on the KOSDAQ.

What Is the Stock Symbol for HLB Therapeutics?

The stock symbol for HLB Therapeutics is "115450."

What Is the HLB Therapeutics Market Cap?

As of today, HLB Therapeutics market cap is 102,77B KRW.

What Is HLB Therapeutics's Earnings Per Share (TTM)?

The HLB Therapeutics EPS (TTM) is -204,44.

From a Technical Analysis Perspective, Is 115450 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has HLB Therapeutics Stock Split?

HLB Therapeutics has split 6 times.

How Many Employees Does HLB Therapeutics Have?

HLB Therapeutics has 49 employees.

What is the current trading status of HLB Therapeutics (115450)?

As of Nov 20, 2026, HLB Therapeutics (115450) is trading at a price of 1 166 KRW, with a previous close of 1 166 KRW. The stock has fluctuated within a day range of 1 159 KRW to 1 289 KRW, while its 52-week range spans from 1 159 KRW to 4 160 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.